Veeva Systems Inc. (VEEV)
NYSE: VEEV · Real-Time Price · USD
283.41
+2.22 (0.79%)
At close: Jun 27, 2025, 4:00 PM
287.25
+3.84 (1.35%)
After-hours: Jun 27, 2025, 7:53 PM EDT
Veeva Systems Revenue
Veeva Systems had revenue of $759.04M in the quarter ending April 30, 2025, with 16.71% growth. This brings the company's revenue in the last twelve months to $2.86B, up 14.78% year-over-year. In the fiscal year ending January 31, 2025, Veeva Systems had annual revenue of $2.75B with 16.20% growth.
Revenue (ttm)
$2.86B
Revenue Growth
+14.78%
P/S Ratio
15.99
Revenue / Employee
$391,622
Employees
7,291
Market Cap
46.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jan 31, 2025 | 2.75B | 382.95M | 16.20% |
Jan 31, 2024 | 2.36B | 208.61M | 9.68% |
Jan 31, 2023 | 2.16B | 304.28M | 16.44% |
Jan 31, 2022 | 1.85B | 385.71M | 26.33% |
Jan 31, 2021 | 1.47B | 360.99M | 32.70% |
Jan 31, 2020 | Pro | Pro | Pro |
Jan 31, 2019 | Pro | Pro | Pro |
Jan 31, 2018 | Pro | Pro | Pro |
Jan 31, 2017 | Pro | Pro | Pro |
Jan 31, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
VEEV News
- 3 days ago - Veeva and AWS Expand 10-Year Relationship - Business Wire
- 4 days ago - Veeva's Rally Could Be A Bull Trap - A Prolonged Consolidation Looms - Benzinga
- 10 days ago - Veeva Systems: The Strong Quarter May Be A First Of Many To Come - Seeking Alpha
- 17 days ago - Medtech Industry Establishes Foundation for Clinical Trials with Veeva MedTech - PRNewsWire
- 19 days ago - New Study Finds 88% of Medtechs Prioritizing Postmarket Quality Modernization Within Next 3 Years - PRNewsWire
- 23 days ago - Veeva Systems: AI And Vault CRM Are Key Long-Term Tailwinds - Seeking Alpha
- 23 days ago - Veeva Systems Inc. (VEEV) Presents at Annual William Blair Growth Stock Conference Transcript - Seeking Alpha
- 24 days ago - Veeva and Sarah Cannon Research Institute Form Strategic Collaboration to Advance Oncology Clinical Trials - PRNewsWire